Scope
This is the NICE guideline Overweight and obesity management (NG246). It covers overweight, obesity and central adiposity across all ages. Its recommendations carry dated tags from 2006 to 2025, and some are marked as amended in 2026. For clinicians, the guideline covers sensitive, permission-based discussion; BMI and waist-to-height ratio thresholds, including ethnicity-adjusted cut-offs; comorbidity assessment; and referral to behavioural or specialist services. It also covers dietary and physical activity approaches, low- and very-low-energy diets, weight management medicines, and bariatric surgery referral and follow-up. It contains extensive prevention, school, workplace and commissioning recommendations, which are summarised only selectively here.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Communication and measurement
- Seek permission every time before raising weight or taking measurements. Do not attribute all symptoms to excess weight (diagnostic overshadowing). Use non-stigmatising, person-first language. [1]
- In adults with BMI below 35 kg/m2, use waist-to-height ratio alongside BMI to estimate central adiposity. Bioimpedance should not replace BMI as a measure of general adiposity. [1]
Classification and comorbidity assessment
- Adult BMI categories are as follows: - healthy weight: 18.5 kg/m2 to 24.9 kg/m2 - overweight: 25 kg/m2 to 29.9 kg/m2 - obesity class 1: 30 kg/m2 to 34.9 kg/m2 - obesity class 2: 35 kg/m2 to 39.9 kg/m2 - obesity class 3: 40 kg/m2 or more Apply clinical judgement in the healthy-weight range because central adiposity may still be present. Interpret BMI cautiously in people with high muscle mass and in people aged 65 and over. [1]
- Lower BMI thresholds apply to people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African–Caribbean background: - overweight: 23 kg/m2 to 27.4 kg/m2 - obesity: 27.5 kg/m2 or above Obesity classes 2 and 3 are usually identified by subtracting 2.5 kg/m2 from the standard thresholds. [1]
- Adult waist-to-height ratio bands are as follows: - 0.4 to 0.49: healthy, with no increased risk - 0.5 to 0.59: increased risk - 0.6 or more: further increased risk These bands apply to both sexes and all ethnicities when BMI is under 35 kg/m2, including people with high muscle mass. [1]
- In children, use BMI centile charts adjusted for age and sex. The categories are: - overweight: 91st centile + 1.34 SDs - clinical obesity: 98th centile + 2.05 SDs - severe obesity: 99.6th centile + 2.68 SDs [1]
- Consider measuring waist circumference in children and young people aged 5 years and over, and calculating waist-to-height ratio to predict central adiposity risk. When talking to a child or young person aged 5 years or over and their families and carers, explain that they should try to keep the waist below half of height. [1]
- Manage comorbidities as soon as they are identified rather than waiting for weight loss. In children with BMI at or above the 98th centile, comorbidity assessment may be considered. [1]
Discussing results and referral
- Emphasise the adult's choice of referral, which may be to in-person individual, group or digital services. Disclose any known costs. If referral is declined, ensure the person has the opportunity to discuss it again in future. Allow re-referral as needed, since management is long-term. [1]
- Adults with weight-related comorbidities should be offered a higher level of intervention. Specialist service referral may be considered when: - underlying causes need assessment - less intensive management has failed - a very-low-calorie diet may be needed - surgery or certain medicines are being considered [1]
- For growing children, weight maintenance that lets BMI centile fall with growth is a realistic goal. Refer children only to behavioural programmes that offer longer-term support and maintenance advice, where these are available locally. [1]
- Children with weight-related comorbidities, or who need specialist support, should be offered a higher level of intervention. Options include specialist services such as CEW clinics (if available) or paediatric services. Specialist assessment should include investigations such as lipid profile (preferably fasting) and fasting glucose with oral glucose tolerance. [1]
Behavioural, physical activity and dietary approaches
- Children's behavioural programmes should: - be multicomponent and individually tailored - include maintenance advice - encourage the whole family to eat healthily and be active, regardless of weight Refer to the local mental health pathway if weight and mental wellbeing appear linked or an eating disorder is suspected. [1]
- Encourage physical activity in adults even without weight loss. To prevent obesity, most people may need 45 to 60 minutes of moderate-intensity activity daily, particularly if they do not reduce their energy intake. After weight loss, 60 to 90 minutes daily may be needed to avoid regain. Children already living with overweight or obesity may need more than the standard recommended amount. [1]
- Adult dietary approaches should create an energy deficit. For children, keep energy intake at or below the recommended level for age and sex, depending on their level of overweight or obesity and any weight-related comorbidities. Favour healthy eating over overly restrictive diets, and do not rely on diet alone. Advise against nutritionally unbalanced restrictive diets. [1]
- Low-energy diets (800 to 1,200 kcal/day) may be considered for adults with obesity, or with overweight plus type 2 diabetes. They should be used only within a multicomponent strategy with long-term support in specialist or long-term-condition services. [1]
- Very-low-energy diets (under 800 kcal/day) may be considered within specialist services for people with obesity who have a clinically assessed need for rapid weight loss, such as to make surgery safer and more feasible. Neither low- nor very-low-energy diets should exceed 12 weeks or serve as a long-term strategy. [1]
Weight management medicines
- Consider the medicine options in table 1 only after dietary, exercise and behavioural approaches have been started and evaluated. Any medicine should accompany a reduced-calorie diet and increased activity. Semaglutide and liraglutide are for specialist services. For tirzepatide, semaglutide and liraglutide, BMI thresholds are usually lowered by 2.5 kg/m2 for the listed ethnic groups. [1]
- Review medicine effect and adherence regularly. Offer weight-maintenance support when medicines are stopped. In people with type 2 diabetes, allow for slower weight loss when setting goals. [1]
- Weight management medicines are not generally recommended for children younger than 12 years. Exceptions are severe comorbidities, with prescribing started and monitored in specialist paediatric settings. From 12 years, orlistat is recommended only with physical or severe psychological comorbidities and specialist multidisciplinary initiation (off-label as of June 2023). Use a 6- to 12-month trial with regular review. [1]
Bariatric surgery
- Offer adults specialist multidisciplinary assessment for bariatric surgery if they meet both conditions: - BMI of 40 kg/m2 or more, or 35 kg/m2 to 39.9 kg/m2 with a significant health condition that could be improved if they lost weight - agreement to the necessary long-term follow-up after surgery (for example, lifelong annual reviews) A threshold 2.5 kg/m2 lower may be considered for the listed ethnic groups. [1]
- For type 2 diabetes diagnosed within the past 10 years, expedited surgical assessment depends on BMI: - BMI 35 kg/m2 or more: offer expedited assessment - BMI 30 to 34.9 kg/m2: consider expedited assessment In both cases, this applies to people who are also receiving, or will receive, assessment in a specialist service. [1]
- After surgery, provide at least 2 years of follow-up within the bariatric service. After discharge from that service, offer at least annual nutritional monitoring and supplementation under shared care with primary care. [1]
- Obesity surgery is not generally recommended in children or young people. It may be considered only in exceptional circumstances near or at physiological maturity. A full medical evaluation, including genetic assessment, should precede surgery to exclude rare treatable causes. [1]
Limitations and use
- Research recommendations (for example on intermittent fasting and psychological therapies for weight stigma), rationale and impact sections, and the evidence reviews are not covered.
- Table 1 drug-specific details are not fully summarised and should be read on the original page. These include the eligibility criteria for tirzepatide, semaglutide, liraglutide and orlistat, as well as prescribing setting, contraception requirements and stopping rules. The guideline also defers to the respective NICE technology appraisals.
- The extensive prevention, school, workplace, local partnership, commissioning and audit recommendations are only minimally represented here.
- The orlistat recommendations for children and young people were described as off-label use as of June 2023.
- The guideline is written for the UK/NHS context and references UK programmes and services.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Overweight and obesity management
Guideline recommendation text consulted
Publication details
- Issuing organisation
- NICE
- First published
- 14 January 2025
- Publisher’s latest update
- 8 January 2026
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.